Daniela J. Conrado

Machine Learning in Drug Discovery and Development Part 1: A Primer

Alan Talevi, Juan Francisco Morales, Gregory Hather et al. · CPT Pharmacometrics & Systems Pharmacology · 2020 · 79 citations · Full text

Artificial Intelligence, Drug Target, Development Part 1 +19

Dopamine Transporter Neuroimaging as an Enrichment Biomarker in Early Parkinson's Disease Clinical Trials: A Disease Progression Modeling Analysis

Daniela J. Conrado, Timothy Nicholas, Kuenhi Tsai et al. · Clinical and Translational Science · 2017 · 45 citations · Full text

Neurophysiological Biomarkers, Neurochemical Biomarkers, Early Parkinson +17

The Qualification of an Enrichment Biomarker for Clinical Trials Targeting Early Stages of Parkinson’s Disease

Diane Stephenson, Jesse M. Cedarbaum, Maria Tome et al. · Journal of Parkinson s Disease · 2019 · 43 citations · Full text

Clinical Neurology, Neurophysiological Biomarkers, Neurochemical Biomarkers +24

An updated Alzheimer’s disease progression model: incorporating non-linearity, beta regression, and a third-level random effect in NONMEM

Daniela J. Conrado, William S. Denney, Danny Chen et al. · Journal of Pharmacokinetics and Pharmacodynamics · 2014 · 40 citations

Neurodegenerative Diseases, Alzheimer's Disease, Aging +10

Model‐Informed Development and Registration of a Once‐Daily Regimen of Extended‐Release Tofacitinib

M. Lamba, MM Hutmacher, D.E. Furst et al. · Clinical Pharmacology & Therapeutics · 2016 · 38 citations · Full text